What Changed
Price Move History
- Daily moves over 5%
- 0 11 sessions, November 5, 2024 to July 23, 2025
- Largest daily move
- +3.3% close of June 25, 2025
- 1-month change
- +5.1% closing prices, June 6, 2025 to July 23, 2025
Company Description
CACTUS ACQ 1 A (OTC: CCTSF) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $43.2M.
CCTSF has gained 6.6% so far this year. The last closing price was $11.79.
For FY2025, CACTUS ACQ 1 A reported net income of -$559K.
This page collects what Stock Titan holds for CCTSF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
CACTUS ACQ 1 A (CCTSF) closed at $11.79 on July 23, 2025. So far this year, the price has gained 6.6%.
CCTSF Metrics & Rankings
Price returns through July 23, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
CACTUS ACQ 1 A has filed 10 recent SEC filings, including 2 Form 10-Q, 1 Form 425, 1 Form DEF 14A, 1 Form PRE 14A. The most recent filing was submitted on October 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CCTSF SEC filings →
Financial Highlights
net income was -$559K. The company generated -$130K in operating cash flow. The current ratio was 0.02, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in CACTUS ACQ 1 A (CCTSF) currently stands at 1.9 thousand shares, representing 0.3% of the float.
Days to Cover History
Days to cover for CACTUS ACQ 1 A (CCTSF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 95.0 to 1000.0 days.
CCTSF Company Profile & Sector Positioning
CACTUS ACQ 1 A (CCTSF) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC.